on 09 Mar 2022
Last Applicant/ Owned by
Oxford BioMedica plc
Windrush Court, Transport Way
Oxford, , OX4 6LT
Serial Number
UK00003763706 filed on 09th Mar 2022
Registration Number
UK00003763706 registered on
14th Oct 2022
Correspondent Address
Lacon London, 84 Theobalds Road, Holborn
London,
WC1X 8NL
Viral vector, retroviral vector, lentiviral vector and non-viral vector manufacturing preparations; biochemical and chemical products for use in medical science.
Therapeutic and prophylactic pharmaceutical products; gene therapy products; vaccines; pharmaceuticals in the form of nanoparticles for delivery; pharmaceutical substances and preparations; pharmaceutical substances and preparations, nanoparticles, viral vectors, retroviral vectors, lentiviral vectors and non-viral vectors for the delivery of genes to cells, all for medical purposes; vaccine manufacturing preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes.
Custom manufacture of products relating to biotechnology; manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; biotechnology contract manufacturing services; contract manufacturing of viral and non-viral vectors; manufacture of vaccines.
Research and laboratory analytic and diagnostic services; design of manufacturing facilities; quality control and validation services; Product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services; research and development services; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research; industrial analysis services; provision of information relating to scientific research; provision of scientific information; research and scientific analysis relating to drug discovery and development for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research; biological research, clinical research and medical research; clinical research; conducting clinical trials; manufacturing development services.
Medical diagnostic services; information relating to pharmaceuticals, bioceuticals and advanced therapy medicinal products; writing reports on pharmaceuticals, bioceuticals and advanced therapy medicinal products; preparation of medical reports; consultancy, advice and information in the field of clinical trials, healthcare, pharmaceuticals and advanced therapy medicinal products; advisory services relating to vaccination regimes; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, and pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals. .
Preparation and review of reports for regulatory approval of pharmaceuticals and bioceuticals; information, consultancy and advice relating to regulatory approval of advanced therapy medicinal products; licensing and management of intellectual property; consultancy, advice and information in the field of drug regulatory approval; regulatory advice relating to chemistry manufacturing and controls (CMC) activities.
UK00003763706
Word
Individual